Statewide

Nebraska Board of Emergency Medical Services

May be outdated195 dose entries63 drugs5 documentsNEeffective 2024-05-0199% machine-parsed of 195

Nebraska Board of Emergency Medical Services (NE) carries 63 drugs across 195 dose entries in its current published protocol, effective 2024-05-01.

The current listed document is more than 24 months old and may be outdated.

Drugs and doses63

Acetaminophen

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	325–1000 mg	PO	not captured	standing	pages 133, 134, 137, 167, 168 · source
Mild to moderate pain	adult	650 mg	IV	not captured	standing	pages 134, 137, 168 · source
Mild to moderate pain	peds	10–15 mg/kg	PO	not captured	standing	pages 133, 134, 137, 167, 168 · source
Mild to moderate pain	peds	12.5 mg/kg	IV	not captured	standing	pages 134, 137, 168 · source

Adenosine

Indication	Population	Dose	Route	Repeat	Standing	Source
Narrow-complex tachycardia	adult	6 mg	IV	not captured	standing	pages 32, 104, 158 · source
Narrow-complex tachycardia	peds	0.1 mg/kg	IV	not captured	standing	pages 32, 104, 158 · source

Albuterol

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	2.5 mg	NEB	not captured	standing	pages 23, 97 · source
Allergic reaction	peds	2.5 mg	NEB	not captured	standing	pages 23, 97 · source
Asthma / bronchospasm	adult	2.5 mg	NEB	not captured	standing	pages 54, 113, 162 · source
Asthma / bronchospasm	peds	2.5 mg	NEB	not captured	standing	pages 54, 113, 162 · source
Crush injury	adult	15 mg	NEB	not captured	standing	pages 74, 128 · source
Crush injury	peds	5 mg	NEB	not captured	standing	pages 74, 128 · source
Hyperkalemia	adult	15 mg	NEB	not captured	standing	pages 28, 34, 58, 74, 128, 162 · source
Other	adult	2.5 mg	NEB	not captured	standing	page 55 · source
Other	adult	2.5 mg	NEB	not captured	standing	pages 57, 116 · source
Other	peds	2.5 mg	NEB	not captured	standing	page 55 · source
Other	peds	2.5 mg	NEB	not captured	standing	pages 57, 116 · source

Aminophylline

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	5 mg/kg	IV/IO	not captured	standing	page 162 · source

Amiodarone

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	150 mg	IV/IO	not captured	standing	page 32 · source
Narrow-complex tachycardia	adult	150 mg	IV/IO	not captured	standing	page 158 · source
Narrow-complex tachycardia	peds	5 mg/kg	IV/IO	not captured	standing	page 158 · source
VF / pulseless VT	adult	300 mg	IV/IO	not captured	standing	pages 27, 101 · source
VF / pulseless VT	peds	5 mg/kg	IV/IO	not captured	standing	pages 27, 101 · source

Aspirin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	324 mg	PO	not captured	standing	pages 38, 40, 167 · source
ACS / chest pain	adult	324 mg	PR	not captured	standing	page 38 · source

Atropine

Indication	Population	Dose	Route	Repeat	Standing	Source
Bradycardia	adult	0.5 mg	IV/IO	not captured	standing	pages 33, 158 · source
Bradycardia	peds	0.02 mg/kg	IV/IO	not captured	standing	pages 33, 158 · source
Organophosphate poisoning	peds	0.02 mg/kg	IV/IO	not captured	standing	page 158 · source
RSI induction	adult	0.5 mg	IV/IO	not captured	standing	pages 139, 141 · source
RSI induction	peds	0.01–0.02 mg/kg	IV/IO	not captured	standing	pages 139, 141 · source

Calcium Chloride

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	5 mL	IV/IO	not captured	standing	pages 63, 163 · source
Hyperkalemia	adult	5–10 mL	IV/IO	not captured	standing	page 163 · source
Other	adult	5–10 mL	IV/IO	not captured	standing	page 28 · source

Calcium Gluconate

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	15 mL	IV/IO	not captured	standing	pages 63, 163 · source
Hyperkalemia	adult	15–30 mL	IV/IO	not captured	standing	page 163 · source
Other	adult	15–30 mL	IV/IO	not captured	standing	page 28 · source

Clopidogrel

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	300 mg	PO	not captured	standing	pages 38, 168 · source

Dexamethasone

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.6 mg/kg	IV/IO	not captured	standing	pages 164, 166 · source
Other	peds	0.6 mg/kg	IV/IO	not captured	standing	pages 164, 166 · source

Dextrose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	12.5–50 g	IV/IO	not captured	standing	pages 46, 108 · source
Hypoglycemia	peds	5 mL/kg	IV/IO	not captured	standing	pages 46, 108 · source

Diazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2–4 mg	IV/IO	not captured	standing	pages 62, 120 · source
Other	peds	0.04–0.2 mg/kg	IV/IO	not captured	standing	pages 62, 120 · source
Procedural sedation	adult	2–4 mg	IV/IO/PR	not captured	standing	pages 136, 141, 161 · source
Procedural sedation	peds	0.04–0.2 mg/kg	IV/IO/PR	not captured	standing	pages 136, 141, 161 · source
Seizure	adult	2–4 mg	IV/IO	not captured	standing	pages 59, 117, 121 · source

Diltiazem

Indication	Population	Dose	Route	Repeat	Standing	Source
Narrow-complex tachycardia	adult	0.25 mg/kg	IV/IO	not captured	standing	page 158 · source

Diphenhydramine

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	25–50 mg	IV/IO	not captured	standing	pages 23, 97, 160 · source
Allergic reaction	peds	1–2 mg/kg	IV/IO	not captured	standing	pages 23, 97, 160 · source

Dobutamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypotension / shock	adult	2–20 mcg/kg	IV/IO	not captured	standing	page 167 · source
Hypotension / shock	peds	2–20 mcg/kg	IV/IO	not captured	standing	page 167 · source

Dopamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Bradycardia	adult	5–20 mcg/kg	IV	not captured	standing	page 33 · source
Other	adult	2–20 mcg/kg	IV/IO	not captured	standing	page 167 · source
Other	peds	2–20 mcg/kg	IV/IO	not captured	standing	page 167 · source

Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	0.3 mg	IM	not captured	standing	pages 23, 97 · source
Anaphylaxis	peds	0.01 mg/kg	SQ	not captured	standing	pages 23, 97 · source
Anaphylaxis	peds	0.15 mg	IM	not captured	standing	pages 23, 97 · source
Anaphylaxis	peds	0.3 mg	IV/IO	not captured	standing	pages 23, 97 · source
Bradycardia	adult	2–10 mcg	IV	not captured	standing	page 33 · source
Cardiac arrest	adult	1 mg	IV/IO	not captured	standing	pages 27, 101 · source
Cardiac arrest	peds	0.01 mg/kg	IV/IO	not captured	standing	pages 27, 101 · source
Croup	peds	0.5 mL/kg	NEB	not captured	standing	page 114 · source
Other	adult	0.3 mg	IM	not captured	standing	pages 54, 113 · source
Other	adult	3–5 mL	NEB	not captured	standing	pages 54, 113 · source
Other	peds	0.01 mg/kg	IM	not captured	standing	pages 54, 113 · source
Other	peds	3–5 mg	NEB	not captured	standing	pages 54, 113 · source
Other	peds	3–5 mg	NEB	not captured	standing	page 116 · source

Etomidate

Indication	Population	Dose	Route	Repeat	Standing	Source
Procedural sedation	adult	0.1–0.15 mg/kg	IV/IO	not captured	standing	page 136 · source
Procedural sedation	peds	0.1–0.2 mg/kg	IV/IO	not captured	standing	page 136 · source
RSI induction	adult	0.3 mg/kg	IV/IO	not captured	standing	pages 141, 165 · source
RSI induction	peds	0.3 mg/kg	IV/IO	not captured	standing	pages 141, 165 · source

Fentanyl

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	25–100 mcg	IV/IO/IM/IN	not captured	standing	page 51 · source
Other	adult	25–100 mcg	IV/IO/IM/IN	not captured	standing	page 80 · source
Mild to moderate pain	adult	25–100 mcg	IV/IO/IM/IN	not captured	standing	pages 22, 96, 134, 137 · source
Mild to moderate pain	peds	1–2 mcg/kg	IV/IO/IM/IN	not captured	standing	pages 22, 96, 134, 137 · source

Furosemide

Indication	Population	Dose	Route	Repeat	Standing	Source
CHF / pulmonary edema	adult	20–80 mg	IV/IO	not captured	standing	page 163 · source

Glucagon

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	1 mg	IM/IN	not captured	standing	pages 46, 108 · source
Hypoglycemia	peds	0.5 mg	IM/IN	not captured	standing	pages 46, 108 · source

Haloperidol

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	2.5–5 mg	IV/IO/IM	not captured	standing	pages 24, 161 · source

Hydralazine

Indication	Population	Dose	Route	Repeat	Standing	Source
Eclampsia / pre-eclampsia	adult	5 mg	IV	not captured	standing	page 81 · source

Hydroxocobalamin

Indication	Population	Dose	Route	Repeat	Standing	Source
Cyanide poisoning	adult	5 g	IV/IO	not captured	standing	pages 64, 160 · source
Other	adult	5 g	IV/IO	not captured	standing	page 28 · source

Ibuprofen

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	400 mg	PO	not captured	standing	pages 133, 137, 167 · source
Mild to moderate pain	peds	5–10 mg/kg	PO	not captured	standing	pages 133, 137, 167 · source

Ipratropium

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	0.5 mg	NEB	not captured	standing	pages 23, 97, 162 · source
Allergic reaction	peds	0.5 mg	NEB	not captured	standing	pages 23, 97, 162 · source
Asthma / bronchospasm	adult	0.5 mg	NEB	not captured	standing	pages 54, 113, 162 · source
Asthma / bronchospasm	peds	0.5 mg	NEB	not captured	standing	pages 54, 113, 162 · source
Other	adult	0.5 mg	NEB	not captured	standing	pages 55, 162 · source
Other	adult	0.5 mg	NEB	not captured	standing	pages 57, 116, 162 · source
Other	peds	0.5 mg	NEB	not captured	standing	pages 55, 162 · source
Other	peds	0.5 mg	NEB	not captured	standing	pages 57, 116, 162 · source

Ketamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiac arrest	adult	0.5–1 mg/kg	IV	not captured	standing	page 43 · source
Cardiac arrest	adult	2–3 mg/kg	IM	not captured	standing	page 43 · source
Hyperactive delirium	adult	4 mg/kg	IM	not captured	standing	page 24 · source
RSI induction	adult	1.5–2 mg/kg	IV/IO	not captured	standing	pages 141, 165 · source
RSI induction	peds	2–4 mg/kg	IV/IO	not captured	standing	pages 141, 165 · source

Ketorolac

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	15–30 mg	IV	not captured	standing	page 22 · source
Mild to moderate pain	adult	15–30 mg	IV/IM	not captured	standing	pages 137, 158 · source
Mild to moderate pain	peds	0.5 mg/kg	IV/IM	not captured	standing	pages 137, 158 · source

Labetalol

Indication	Population	Dose	Route	Repeat	Standing	Source
Eclampsia / pre-eclampsia	adult	10–20 mg	IV	not captured	standing	page 81 · source

Levosalbutamol

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	0.63 mg	NEB	not captured	standing	page 163 · source
Asthma / bronchospasm	peds	0.31 mg	NEB	not captured	standing	page 163 · source

Lidocaine

Indication	Population	Dose	Route	Repeat	Standing	Source
RSI induction	adult	1–4 mg	IV/IO	not captured	standing	page 158 · source
RSI induction	peds	20–50 mcg	IV/IO	not captured	standing	page 158 · source
Narrow-complex tachycardia	adult	1–1.5 mg/kg	IV/IO	not captured	standing	page 158 · source
Narrow-complex tachycardia	peds	1 mg/kg	IV/IO	not captured	standing	page 158 · source
VF / pulseless VT	adult	1–1.5 mg/kg	IV/IO	not captured	standing	pages 27, 101, 158 · source
VF / pulseless VT	peds	1 mg/kg	IV/IO	not captured	standing	pages 27, 101, 158 · source

Lorazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	0.5 mg	IV/IO/IN	not captured	standing	pages 24, 161 · source
Agitation	peds	0.05 mg/kg	IV/IO/IN	not captured	standing	pages 24, 161 · source
RSI induction	adult	2–4 mg	IV/IO	not captured	standing	pages 141, 161 · source
RSI induction	peds	0.1 mg/kg	IV/IO	not captured	standing	pages 141, 161 · source

Magnesium Sulfate

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	1–2 g	IV/IO	not captured	standing	pages 54, 113 · source
Asthma / bronchospasm	adult	1–2 g	IV/IO	not captured	standing	page 163 · source
Asthma / bronchospasm	peds	25 mg/kg	IV/IO	not captured	standing	pages 54, 113 · source
Asthma / bronchospasm	peds	25–50 mg/kg	IV/IO	not captured	standing	page 163 · source
Eclampsia / pre-eclampsia	adult	2–4 g	IV/IO	not captured	standing	pages 81, 163 · source
Other	adult	1–2 g	IV/IO	not captured	standing	page 28 · source

Metaproterenol

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	10–15 mg	NEB	not captured	standing	page 162 · source
Asthma / bronchospasm	peds	0.1 mL	NEB	not captured	standing	page 162 · source

Methohexital

Indication	Population	Dose	Route	Repeat	Standing	Source
RSI induction	adult	1–1.5 mg/kg	IV/IO	not captured	standing	pages 141, 165 · source
RSI induction	peds	25 mg/kg	PR	not captured	standing	pages 141, 165 · source
RSI induction	peds	6.6–10 mg/kg	IM	not captured	standing	pages 141, 165 · source

Methylprednisolone

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	125–250 mg	IV/IO	not captured	standing	pages 23, 97, 166 · source
Allergic reaction	peds	2 mg/kg	IV/IO	not captured	standing	pages 23, 97, 166 · source
Asthma / bronchospasm	adult	125–250 mg	IV/IO	not captured	standing	pages 54, 113, 166 · source
Asthma / bronchospasm	peds	2 mg/kg	IV/IO	not captured	standing	pages 54, 113, 166 · source
Other	adult	125–250 mg	IV/IO	not captured	standing	pages 57, 116, 166 · source
Other	peds	2 mg/kg	IV/IO	not captured	standing	pages 57, 116, 166 · source

Metoclopramide

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	5–10 mg	IV/IM/PO	not captured	standing	page 160 · source
Other	adult	5–10 mg	IV/IM	not captured	standing	pages 49, 160 · source

Metoprolol

Indication	Population	Dose	Route	Repeat	Standing	Source
Narrow-complex tachycardia	adult	5 mg	IV	not captured	standing	page 158 · source

Midazolam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	0.05 mg/kg	IV/IO/IM/IN	not captured	standing	pages 24, 161 · source
Agitation	peds	0.1 mg/kg	IV/IO/IM/IN	not captured	standing	pages 24, 161 · source
RSI induction	adult	2–6 mg	IV/IO/IM/IN	not captured	standing	pages 141, 161 · source
RSI induction	peds	0.2–0.3 mg/kg	IV/IO/IM/IN	not captured	standing	pages 141, 161 · source

Morphine

Indication	Population	Dose	Route	Repeat	Standing	Source
Burns	adult	2–4 mg	IV/IO	not captured	standing	pages 73, 127 · source
Burns	peds	0.05–0.2 mg/kg	IV/IO	not captured	standing	pages 73, 127 · source
Crush injury	adult	2–4 mg	IV/IO	not captured	standing	pages 74, 128 · source
Crush injury	peds	0.05–0.2 mg/kg	IV/IO	not captured	standing	pages 74, 128 · source
Other	adult	2–4 mg	IV/IO	not captured	standing	page 72 · source
Other	adult	2–4 mg	IV/IO	not captured	standing	page 77 · source
Other	adult	2–4 mg	IV/IO/IM/IN	not captured	standing	page 80 · source
Other	adult	2–4 mg	IV/IO/IM/IN	not captured	standing	page 51 · source
Other	peds	0.05–0.2 mg/kg	IV/IO/IN	not captured	standing	page 130 · source
Mild to moderate pain	adult	2–4 mg	IV/IO/IM/IN	not captured	standing	pages 22, 80, 96, 134, 137 · source
Mild to moderate pain	peds	0.05–0.2 mg/kg	IV/IO/IM/IN	not captured	standing	pages 22, 80, 96, 134, 137 · source

Naloxone

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.4–4 mg	IV/IO/IM/IN	not captured	standing	pages 44, 63, 106, 121, 159 · source
Other	peds	0.1 mg/kg	IV/IO/IM/IN	not captured	standing	pages 44, 63, 106, 121, 159 · source

Nerve Agent Antidote Kit

Indication	Population	Dose	Route	Repeat	Standing	Source
Organophosphate poisoning	adult	Three Each (Mark I) or Three (DouDote)	not captured	not captured	standing	pages 60, 118, 159 · source
Organophosphate poisoning	peds	Age 3-7: One Each (Mark I) or One (DouDote); Age 8-12: Two Each (Mark I) or Two (DouDote)	not captured	not captured	standing	pages 60, 118, 159 · source

Nicardipine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2.5 mg	IV	not captured	standing	page 161 · source

Nitroglycerin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	0.4 mg	SL	not captured	standing	pages 38, 40, 166 · source
CHF / pulmonary edema	adult	0.4 mg	SL	not captured	standing	page 42 · source

Norepinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypotension / shock	peds	0.1–2 mcg/kg	IV	not captured	standing	page 167 · source

Ondansetron

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	4–8 mg	IV/IO/ODT	not captured	standing	pages 50, 110, 160 · source
Nausea / vomiting	peds	0.1 mg/kg	IV/IO/ODT	not captured	standing	pages 50, 110, 160 · source

Oral Glucose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	15 g	PO	not captured	standing	pages 46, 108 · source
Hypoglycemia	peds	7.5–15 g	PO	not captured	standing	pages 46, 108 · source

Pancuronium

Indication	Population	Dose	Route	Repeat	Standing	Source
RSI induction	adult	0.04–0.1 mg/kg	IV/IO	not captured	standing	pages 140, 142, 165 · source
RSI induction	peds	0.04–0.1 mg/kg	IV/IO	not captured	standing	pages 140, 142, 165 · source

Pralidoxime

Indication	Population	Dose	Route	Repeat	Standing	Source
Organophosphate poisoning	adult	600–1200 mg	IV/IO	not captured	standing	pages 64, 121, 159 · source
Organophosphate poisoning	peds	20–50 mg/kg	IV/IO	not captured	standing	pages 64, 121, 159 · source

Procainamide

Indication	Population	Dose	Route	Repeat	Standing	Source
Narrow-complex tachycardia	adult	20–50 mg	IV	not captured	standing	pages 32, 159 · source

Prochlorperazine

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	5–10 mg	IV/IO	not captured	standing	pages 141, 160 · source
Procedural sedation	adult	5 mg	IV/IO	not captured	standing	pages 136, 141 · source

Promethazine

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	12.5–25 mg	IV/IO	not captured	standing	pages 135, 160 · source
Procedural sedation	adult	25 mg	IV/IO	not captured	standing	pages 136, 141 · source
Procedural sedation	peds	0.5–1 mg/kg	IV/IO	not captured	standing	pages 136, 141 · source

Propofol

Indication	Population	Dose	Route	Repeat	Standing	Source
RSI induction	adult	1–2 mg/kg	IV/IO	not captured	standing	pages 141, 165 · source
RSI induction	peds	1–2 mg/kg	IV/IO	not captured	standing	pages 141, 165 · source

Racemic Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	0.5–0.75 mL	NEB	not captured	standing	page 162 · source
Asthma / bronchospasm	peds	0.25 mL	NEB	not captured	standing	page 162 · source
Croup	adult	0.5–0.75 mL	NEB	not captured	standing	page 162 · source
Croup	peds	0.25 mL	NEB	not captured	standing	page 162 · source
Other	adult	0.5–0.75 mL	NEB	not captured	standing	page 162 · source
Other	peds	0.25 mL	NEB	not captured	standing	page 162 · source

Rocuronium

Indication	Population	Dose	Route	Repeat	Standing	Source
RSI induction	adult	0.6–1.2 mg/kg	IV/IO	not captured	standing	pages 139, 140, 142, 165 · source
RSI induction	peds	0.6–1.2 mg/kg	IV/IO	not captured	standing	pages 139, 140, 142, 165 · source

Sodium Bicarbonate

Indication	Population	Dose	Route	Repeat	Standing	Source
Crush injury	adult	50 mEq	IV/IO	not captured	standing	pages 74, 128 · source
Crush injury	peds	1 mEq/kg	IV/IO	not captured	standing	pages 74, 128 · source
Other	adult	50 mEq	IV/IO	not captured	standing	page 28 · source
Tricyclic overdose	adult	50 mEq	IV/IO	not captured	standing	pages 63, 121 · source
Tricyclic overdose	peds	1 mEq/kg	IV/IO	not captured	standing	pages 63, 121 · source

Sotalol

Indication	Population	Dose	Route	Repeat	Standing	Source
Narrow-complex tachycardia	adult	100 mg	IV/IO	not captured	standing	pages 32, 159 · source

Succinylcholine

Indication	Population	Dose	Route	Repeat	Standing	Source
RSI induction	adult	1.5 mg/kg	IV/IO	not captured	standing	pages 139, 164 · source
RSI induction	peds	2 mg/kg	IV/IO	not captured	standing	pages 139, 164 · source

Terbutaline

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	0.25 mg	SQ	not captured	standing	page 162 · source

Thiamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	100 mg	IV/IO	not captured	standing	pages 46, 68, 69, 125 · source
Hypoglycemia	peds	100 mg	IV/IO	not captured	standing	pages 46, 68, 69, 125 · source

Tranexamic Acid

Indication	Population	Dose	Route	Repeat	Standing	Source
Crush injury	adult	1 g	IV	not captured	standing	page 147 · source
Trauma / hemorrhage	adult	1 g	IV	not captured	standing	page 147 · source

Vecuronium

Indication	Population	Dose	Route	Repeat	Standing	Source
RSI induction	adult	0.1 mg/kg	IV/IO	not captured	standing	pages 140, 142, 165 · source
RSI induction	peds	0.1 mg/kg	IV/IO	not captured	standing	pages 140, 142, 165 · source

Cite this

Nebraska Board of Emergency Medical Services, United States EMS Protocol Census. 195 dose entries, effective 2024-05-01.

https://protoquiz.com/census/agencies/nebraska-board-of-emergency-medical-services/

Outdated or wrong?

Send the current document's public URL and the listing is rebuilt from it. To have this agency removed from the census entirely, say so and it comes down the same day.